Company / Cash & Equivalents
Omega Healthcare Investors Cash & Equivalents History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$27.0M
FY2025
5-year range
$20.5M / $518.3M
FY2021-FY2025
Trend
-94.8%
vs FY2024
Sector context
#104 of 133
Real Estate
What the data says
Omega Healthcare Investors's cash & equivalents of $27M is lower than 78% of companies in the Real Estate sector (FY2025). Cash & Equivalents has fluctuated over the past 10 years, ranging from $10M in FY2018 to $518M in FY2024.
Based on SEC 10-K filings.
$27M in FY2025 with a 5-year CAGR of +2.3%.
Declined from $297M to $27M over the past 2 years.
Real Estate sector context is included.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- +9.6%
- 5-Year CAGR
- +2.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Real EstateTop 78% of 133This company $27.0M Sector average $334.0M
▼
-91.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +2.3%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 94.8% year-over-year.
- Ranks #104 out of 133 companies in the Real Estate sector.
- Peak cash & equivalents was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- Strong profit margin: 21.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.0M | -94.8% |
| FY2024 | $518.3M | +74.5% |
| FY2023 | $297.1M | +1346.9% |
| FY2022 | $20.5M | -87.4% |
| FY2021 | $163.5M | +578.1% |
| FY2020 | $24.1M | +0.0% |
| FY2019 | $24.1M | +134.1% |
| FY2018 | $10.3M | -88.0% |
| FY2017 | $85.9M | -8.3% |
| FY2016 | $93.7M | +1627.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026